Novartis names Wyss head of pharma North America

Novartis AG (NYSE:NVS; SIX:NOVN) named Andre Wyss head of pharma North America and president of Novartis Pharmaceuticals Corp. Previously, Wyss was head of region Asia-Pacific, Middle East and African Countries (AMAC) and head of Group Emerging Markets (GEM). The appointment comes after last week's announcement that Novartis was restructuring its U.S. pharma business, a move that included the departure of Ludwig Hantson as head of pharma North America and CEO of Novartis Pharmaceuticals (See BioCentury Extra, Monday, April 19, 2010). ...